Rapid Aneurysm Triage and Notification is an AI-enabled medical device from iSchemaView Inc., listed by FDA (510(k), K230074) with a decision date of 2023-07-27. Review panel: Radiology.
| FDA submission number | K230074 |
|---|---|
| Pathway | 510(k) |
| Company | iSchemaView Inc. |
| Review panel (specialty) | Radiology |
| FDA decision date | 2023-07-27 |
| Decision | Substantially Equivalent |
| Product code | QFM |
| Classification | Radiological Computer-Assisted Prioritization Software For Lesions |
| Device class | 2 |
| Regulation number | 892.2080 |
| Review time (calendar days) | 198 |
| Applicant country | US |
Official FDA database record · FDA AI-enabled device list
More devices from iSchemaView Inc. · All Radiology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.